LY-301317
LY-301317, also known as (R)-4,α-methylene-5-(1,3-oxazol-5-yl)-N,N-dipropyltryptamine ((R)-4,α-methylene-5-(1,3-oxazol-5-yl)-DPT), is a potent and selective serotonin 5-HT 1A receptor agonist which has been used in scientific research.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
LY-301317, also known as (R)-4,α-methylene-5-(1,3-oxazol-5-yl)-N,N-dipropyltryptamine ((R)-4,α-methylene-5-(1,3-oxazol-5-yl)-DPT), is a potent and selective serotonin 5-HT 1A receptor agonist which has been used in scientific research. It is a cyclized tryptamine and a partial ergoline.
The drug shows very high affinity for the serotonin 5-HT 1A receptor, with a K i of 0.26 nM, and is highly selective for this receptor over 9 other assessed targets. It produces various serotonin 5-HT 1A receptor agonist-associated effects in animals, including behavioral effects, hypothermia, antidepressant-like, anxiolytic-like, and antiemetic effects, and discriminative stimulus effects in drug discrimination tests.
LY-301317 was first described in the scientific literature in 1996.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1358480274 under CC BY-SA 4.0; modifications have been made.